Literature DB >> 20927628

Curing the plasmid pXO2 from Bacillus anthracis A16 using plasmid incompatibility.

Huagui Wang1, Xiankai Liu, Erling Feng, Li Zhu, Dongshu Wang, Xiangru Liao, Hengliang Wang.   

Abstract

Plasmid incompatibility, which has no effect on other plasmids or chromosomal genes, can be used to cure a target plasmid. In this report, we successfully cured the plasmid pXO2 from Bacillus anthracis A16 with a newly constructed, incompatible plasmid pKSV7-oriIV and obtained a new pXO2-cured strain, designated A16PI2. This is the first time that a plasmid was cured from the B. anthracis wild-type strain A16 utilizing this principle, which could be considered as an efficacious method to cure large plasmids.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20927628     DOI: 10.1007/s00284-010-9767-2

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  19 in total

1.  Plasmid incompatibility: more compatible than previously thought?

Authors:  Nileena Velappan; Daniele Sblattero; Leslie Chasteen; Peter Pavlik; Andrew R M Bradbury
Journal:  Protein Eng Des Sel       Date:  2007-03-01       Impact factor: 1.650

Review 2.  Polymerases and the replisome: machines within machines.

Authors:  T A Baker; S P Bell
Journal:  Cell       Date:  1998-02-06       Impact factor: 41.582

3.  Efficient gene inactivation in Bacillus anthracis.

Authors:  Konstantin Y Shatalin; Alex A Neyfakh
Journal:  FEMS Microbiol Lett       Date:  2005-04-15       Impact factor: 2.742

4.  Rapid procedure for detection and isolation of large and small plasmids.

Authors:  C I Kado; S T Liu
Journal:  J Bacteriol       Date:  1981-03       Impact factor: 3.490

Review 5.  Anthrax as a biological weapon, 2002: updated recommendations for management.

Authors:  Thomas V Inglesby; Tara O'Toole; Donald A Henderson; John G Bartlett; Michael S Ascher; Edward Eitzen; Arthur M Friedlander; Julie Gerberding; Jerome Hauer; James Hughes; Joseph McDade; Michael T Osterholm; Gerald Parker; Trish M Perl; Philip K Russell; Kevin Tonat
Journal:  JAMA       Date:  2002-05-01       Impact factor: 56.272

6.  Search for potential vaccine candidate open reading frames in the Bacillus anthracis virulence plasmid pXO1: in silico and in vitro screening.

Authors:  N Ariel; A Zvi; H Grosfeld; O Gat; Y Inbar; B Velan; S Cohen; A Shafferman
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

7.  Global effects of virulence gene regulators in a Bacillus anthracis strain with both virulence plasmids.

Authors:  Agathe Bourgogne; Melissa Drysdale; Susan G Hilsenbeck; Scott N Peterson; Theresa M Koehler
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

8.  Genome-based bioinformatic selection of chromosomal Bacillus anthracis putative vaccine candidates coupled with proteomic identification of surface-associated antigens.

Authors:  N Ariel; A Zvi; K S Makarova; T Chitlaru; E Elhanany; B Velan; S Cohen; A M Friedlander; A Shafferman
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

9.  The transformation frequency of plasmids into Bacillus anthracis is affected by adenine methylation.

Authors:  R Marrero; S L Welkos
Journal:  Gene       Date:  1995-01-11       Impact factor: 3.688

10.  Evolutionary history, structural features and biochemical diversity of the NlpC/P60 superfamily of enzymes.

Authors:  Vivek Anantharaman; L Aravind
Journal:  Genome Biol       Date:  2003-02-03       Impact factor: 13.583

View more
  6 in total

Review 1.  Ecology and evolution as targets: the need for novel eco-evo drugs and strategies to fight antibiotic resistance.

Authors:  Fernando Baquero; Teresa M Coque; Fernando de la Cruz
Journal:  Antimicrob Agents Chemother       Date:  2011-05-16       Impact factor: 5.191

2.  Curing of plasmid pXO1 from Bacillus anthracis using plasmid incompatibility.

Authors:  Xiankai Liu; Dongshu Wang; Huagui Wang; Erling Feng; Li Zhu; Hengliang Wang
Journal:  PLoS One       Date:  2012-01-11       Impact factor: 3.240

Review 3.  Targeting Plasmids to Limit Acquisition and Transmission of Antimicrobial Resistance.

Authors:  Corneliu Ovidiu Vrancianu; Laura Ioana Popa; Coralia Bleotu; Mariana Carmen Chifiriuc
Journal:  Front Microbiol       Date:  2020-05-06       Impact factor: 5.640

4.  A CRISPR/Cas12a-based DNAzyme visualization system for rapid, non-electrically dependent detection of Bacillus anthracis.

Authors:  Dongshu Wang; Gang Chen; Yufei Lyu; Erling Feng; Li Zhu; Chao Pan; Weicai Zhang; Xiankai Liu; Hengliang Wang
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 7.163

5.  Application of CRISPR/Cas9 System for Plasmid Elimination and Bacterial Killing of Bacillus cereus Group Strains.

Authors:  Xiaojing Wang; Yufei Lyu; Siya Wang; Qingfang Zheng; Erling Feng; Li Zhu; Chao Pan; Shenghou Wang; Dongshu Wang; Xiankai Liu; Hengliang Wang
Journal:  Front Microbiol       Date:  2021-06-10       Impact factor: 5.640

Review 6.  Strategies to combat antimicrobial resistance: anti-plasmid and plasmid curing.

Authors:  Michelle M C Buckner; Maria Laura Ciusa; Laura J V Piddock
Journal:  FEMS Microbiol Rev       Date:  2018-11-01       Impact factor: 16.408

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.